GlassScriptPhysician profile
Raynald A Samoa
NPI 1629194048
$2,427.07
in general payments reported to CMS, 2019-2025
9 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.03 · 2021: $1,301 · 2022: $103 · 2023: $73.46 · 2024: $184 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500 · Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
| Food and Beverage | $432.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,251.00 | 2021 | |
| Henry Schein, INC. | $500.00 | 2025 | |
| Abbott Laboratories | $350.83 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $215.45 | 2021-2025 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $29.68 | 2023 | Ultomiris |
| Senseonics, Incorporated | $28.00 | 2019 | |
| Insulet Corporation | $25.91 | 2021-2022 | |
| Antares Pharma, INC. | $15.16 | 2021 | |
| Medtronic Minimed, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raynald Samoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.